Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Date Title Source
2022-10-21 6:3:44 am Aditxt’s (Nasdaq: ADTX) Adimune™ Program Has Initiated the Manufacturing Process of Immunotherapeutic Drug Candidate, ADI™-100 in Preparation for Planned Psoriasis First-in-Human Trials BusinessWire
2022-10-12 6:0:0 am Aditxt, Inc. (Nasdaq: ADTX) Announces Development and Publication of a Mathematical Model for Predicting Longevity and Variations of Immune Response to Immunization to SARS-CoV-2 Infection Business Wire
2022-10-07 6:0:0 am FedEx Features AditxtScore™ Immune Monitoring Center and its Service in Richmond, VA, Highlighting the Importance of Quantifying Immune Health Business Wire
2022-09-30 5:34:12 am Is the Options Market Predicting a Spike in Aditx (ADTX) Stock? Zacks
2022-09-29 6:0:0 am Aditxt, Inc. (NASDAQ: ADTX) Announces That it Has Regained Compliance with Nasdaq Listing Requirements Business Wire
2022-09-27 6:0:0 am Aditxt Inc. (Nasdaq: ADTX) Provides Corporate Highlights Post Reverse Stock Split and Closing of $20M Public Offering Business Wire
2022-09-20 1:9:0 pm Aditxt Announces Closing of $20.0 Million Public Offering Business Wire
2022-09-16 6:20:0 am Aditxt Announces Pricing of $20.0 Million Public Offering Business Wire
2022-09-13 1:15:0 pm Aditxt, Inc. (Nasdaq: ADTX) Announces 1-for-50 Reverse Stock Split Effective Pre-Market Opening on September 14, 2022 Business Wire